JPRN-C000000205CompletedPhase 3
Randomized comparative study of cisplatin, docetaxel, and irinotecan versus cisplatin and docetaxel in patients with stage IIIB or stage IV non-small cell lung cancer (OLCSG 0403) - cisplatin, docetaxel, and irinotecan versus cisplatin and docetaxel in patients with stage IIIB or stage IV non-small cell lung cancer
Okayama Lung Cancer Study Group (OLCSG)0 sites120 target enrollmentStarted: September 13, 2005Last updated:
Trial Snapshot
- Phase
- Phase 3
- Status
- Completed
- Sponsor
- Enrollment
- 120
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- ot applicable to 70years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1. Symptomatic brain metastasis 2. Active concomittant malignancy, history of previous chemotherapy or thoracic radiation therapy for malignancy 3. Clinically significant allergic history 4. Pregnant or lactating women 5. Severe comrbidities 1) Active interstial pneumonia 2) Unstable angina pectoris, or recent history of myocardial infarction 3) Uncntrolled diabetes mellitus 4) Sever active infection 5) Pleural effusion or ascites which require treatment 6) Clinically significant pericardial effusion 7) Other clinical condition which is considered as inappropriate for this study
Investigators
Similar Trials
Not yet recruiting
Not Applicable
Comparative response evaluation of Cisplatin-Capecitabine with Cisplatin-5-Fluorouracil in advanced gastric carcinoma.Clinically diagnosed and histopathologically proved advanced gastric carcinoma (AJCC Stage IV).Advanced gastric carcinoma.TCTR20170715001Bangabandhu Sheikh Mujib Medical University62
Completed
Phase 2
A randomized phase II study comparing cisplatin + docetaxel with carboplatin + paclitaxel in patients with Stage III (N 2 positive) non-small-cell lung cancer who receive trimodality treatment consisting of chemoradiotherapy followed by surgery (OLCSG1601)previously untreated non-small-cell lung ccancer, stage III (N2 positive)JPRN-UMIN000024816Okayama Lung Cancer Study Group (OLCSG)80
Not yet recruiting
Phase 2
ANTS Trial (Australian Neoadjuvant Therapy Study for Non-small Cell Lung Cancer)ACTRN12608000061336Austin Health100
Completed
Not Applicable
Randomised study of two doses of cisplatin with cyclophosphamide in epithelial ovarian cancerMalignant neoplasm of ovaryOvarian CancerCancerISRCTN78953383Cancer Research UK (CRUK) (UK)
Completed
Phase 3
Randomized, comparative clinical study of cisplatin and docetaxel combination chemotherapy and mitomycin, vindesine and cisplatin (MVP) combination chemotherapy with concurrent thoracic radiation therapy for locally advanced unresectable non-small-cell lung cancer (OLCSG0007)inoperable locally advanced non-small-cell lung cancerJPRN-C000000085Okayama Lung Cancer Study Group (OLCSG)200